~~<i id='441B038BFF'><strike id='441B038BFF'><tt id='441B038BFF'><pre id='441B038BFF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：leisure time 2025-09-28 15:56:56 - browse：84

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Disclosing genetic information: not as worrisome as once feared

entertainment

explore

Wikipedia

Amonkeypoxvirion,ascapturedinanelectronmicroscopicimage.CDC/CynthiaS.GoldsmithTheCentersforDiseaseCo

WSS

Death of patient in Alzheimer’s trial raises question of possible risks

Colonoscopy at 40? Study finds a possible benefit

In areas with more Black doctors, Black people live longer

Colonoscopy at 40? Study finds a possible benefit

Gene therapy has helped boys walk. Can scientists keep it that way?

Do masks work? RCTs can't tell us

hotspot

focus

entertainment

Jerome Adams on the need for new antivirals for Covid

Fatty liver disease was alleviated by Lilly’s ‘triple

In age of alternative facts, a scholarly course on calling out crap

How Robert F. Kennedy Jr. distorted vaccine science

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why drug prescriptions should include diagnoses

Guidelines to prevent youth baseball injuries need more muscle

The biotech scorecard for Q3: 15 stock

Trump demands the U.S. pay no more for drugs than other countries … again

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

entertainment

Donald Trump's relentless attacks on special counsel Jack Smith

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

'Screen and refer' systems are hurting patients

3 hurdles to bringing medical devices to the U.S. market

#NeedHerScience: shining a light on gender disparities in medicine

Drug cartel violence flares in western Mexico after vigilante leader's killing

explore

Wikipedia

Wikipedia

Wikipedia